IgA nephropathy trials in Australia

In Australia 10 Also abroad 92

10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Where
Box Hill, Clayton, Liverpool, Milton, St Albans
Age
18 years and over
People
347 worldwide
Run by
Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00
Phase 2Taking people
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Where
Concord, Liverpool, Parkville
Age
18 years to 60 years
People
30 worldwide
Run by
Jade Biosciences, Inc.
See details and how to joinNCT07541287
Phase 2Taking people
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Where
Liverpool, Sydney, Wollongong, Woolloongabba
Age
18 years and over
People
45 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06989359
Phase 3Taking people
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Where
Douglas, Herston, New Lambton, New South Wales, Southport, St Albans, St Leonards, Westmead, Woolloongabba
Age
18 years and over
People
454 worldwide
Run by
Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Adelaide, Parkville, Woolloongabba
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 2Taking people
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Where
Clayton, Newcastle, Penrith, Perth, Saint Albans, Sydney, Woolloongabba
Age
18 years and over
People
15
Run by
Sitala Bio LTD
See details and how to joinNCT07606352
Phase 3Taking people
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Where
Brisbane, Nedlands
Age
2 years to 18 years
People
31 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06994845
Phase 3Taking people
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Where
Gosford, Kogarah
Age
18 years to 100 years
People
220 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06858319
Phase 2Taking people
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Where
St Albans, Westmead
Age
18 years to 75 years
People
96 worldwide
Run by
Walden Biosciences
See details and how to joinNCT06466135
Phase 2/3Enrolling by invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Where
Adelaide, Concord, Fitzroy, Garran, Kogarah, Liverpool, New Lambton Heights, Saint Leonards, St Albans
Age
18 years and over
People
600 worldwide
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659